News
HC Wainwright & Co. Maintains Buy on ALX Oncology Holdings, Raises Price Target to $20
11 Mar 24
News, Price Target, Analyst Ratings
ALX Oncology Has 'Elevated Valuation' - Analyst Downgrades Stock, Highlights Need For Development De-Risking Beyond Gastric Cancer
8 Mar 24
Analyst Color, Biotech, Earnings, News, Downgrades, Health Care, Analyst Ratings, Movers, Trading Ideas, General
Piper Sandler Maintains Overweight on ALX Oncology Holdings, Raises Price Target to $21
8 Mar 24
News, Price Target, Analyst Ratings
12 Health Care Stocks Moving In Friday's Pre-Market Session
8 Mar 24
Movers
Stifel Downgrades ALX Oncology Holdings to Hold, Raises Price Target to $14
8 Mar 24
News, Downgrades, Price Target, Analyst Ratings
ALX Oncology Holdings Q4 2023 GAAP EPS $(0.930) Misses $(0.860) Estimate
7 Mar 24
Earnings, Earnings Misses, News
ALX Oncology Announces Two Evorpacept Clinical Abstracts Accepted For Presentation At The AACR Annual Meeting
5 Mar 24
Biotech, News, Events, General